Cohen Klingenstein Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$17.6M |
| 2 |
PepsiCo
PEP
|
+$16.9M |
| 3 |
Walt Disney
DIS
|
+$15.6M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$14.4M |
| 5 |
Honeywell
HON
|
+$4.89M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Growth ETF
IWO
|
+$637K |
| 2 |
Invesco QQQ Trust
QQQ
|
+$460K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$282K |
| 4 |
Nu Skin
NUS
|
+$207K |
| 5 |
BP
BP
|
+$6.45K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 15.56% |
| 2 | Financials | 11.64% |
| 3 | Industrials | 10.96% |
| 4 | Healthcare | 10.5% |
| 5 | Technology | 9.83% |
Similar funds
Cohen Klingenstein's Q3 2019 Portfolio in Review
As of Q3 2019, Cohen Klingenstein held 240 positions worth $1.59B, up 13% from $1.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Cohen Klingenstein deployed $195M of net new capital in Q3 2019, opening 28 new positions and adding to 72 existing holdings. Its largest new stake was Intuitive Surgical: 8,460 shares worth $1.52M.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was iShares Russell 2000 Growth ETF, an estimated $637K trimmed.
- Cohen Klingenstein's largest Q3 2019 buy was Intuitive Surgical: 8,460 shares worth $1.52M.
- Cohen Klingenstein added most to Union Pacific in Q3 2019, an estimated $17.6M increase.
- Cohen Klingenstein's biggest Q3 2019 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $637K.
- Cohen Klingenstein fully exited Nu Skin in Q3 2019, selling an estimated $207K.
- Cohen Klingenstein's ten largest holdings make up 41% of its $1.59B portfolio in Q3 2019.
- Cohen Klingenstein opened 28 new positions and closed 1 in Q3 2019.
- Cohen Klingenstein's portfolio value rose 13% quarter-over-quarter to $1.59B.
Based on Cohen Klingenstein's 13F filing for Q3 2019, filed 17 Oct 2019.